Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.
Messou E, Chaix ML, Gabillard D, Minga A, Losina E, Yapo V, Kouakou M, Danel C, Sloan C, Rouzioux C, Freedberg KA, Anglaret X. Messou E, et al. Among authors: sloan c. J Acquir Immune Defic Syndr. 2011 Apr;56(4):356-64. doi: 10.1097/QAI.0b013e3182084b5a. J Acquir Immune Defic Syndr. 2011. PMID: 21191309 Free PMC article.
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.
Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA; ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA); CEPAC International investigators. Losina E, et al. PLoS Med. 2009 Oct;6(10):e1000173. doi: 10.1371/journal.pmed.1000173. Epub 2009 Oct 27. PLoS Med. 2009. PMID: 19859538 Free PMC article.
The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa.
Walensky RP, Wood R, Fofana MO, Martinson NA, Losina E, April MD, Bassett IV, Morris BL, Freedberg KA, Paltiel AD; Cost-Effectiveness of Preventing AIDS Complications-International Investigators. Walensky RP, et al. J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):26-35. doi: 10.1097/QAI.0b013e3181fb8f24. J Acquir Immune Defic Syndr. 2011. PMID: 21068674 Free PMC article.
Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.
Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA; CEPAC-International Investigators. Walensky RP, et al. J Infect Dis. 2008 May 1;197(9):1324-32. doi: 10.1086/587184. J Infect Dis. 2008. PMID: 18422445 Free PMC article.
Economic evaluation of ART in resource-limited countries.
Loubiere S, Meiners C, Sloan C, Freedberg KA, Yazdanpanah Y. Loubiere S, et al. Among authors: sloan c. Curr Opin HIV AIDS. 2010 May;5(3):225-31. doi: 10.1097/COH.0b013e3283384a9d. Curr Opin HIV AIDS. 2010. PMID: 20539078 Free PMC article. Review.
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.
Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R, Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RP; CEPAC-International and OCTANE Investigators. Ciaranello AL, et al. AIDS. 2011 Feb 20;25(4):479-92. doi: 10.1097/QAD.0b013e3283428cbe. AIDS. 2011. PMID: 21293199 Free PMC article.
334 results